skip to Cookie NoticeSkip to contents

Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs

Header Skipped.

Rheumatology Advances Newsletter

Multidisciplinary Team Delivers Rapid Care for Patients with Giant Cell Arteritis to Prevent Irreversible Vision Loss and Other Serious Complications

Recently established to expedite care for patients with giant cell arteritis, the new Fast Track Clinic for Giant Cell Arteritis comprises a multidisciplinary team of rheumatologists, vascular medicine specialists, vascular surgeons, and pathologists from the Division of Rheumatology, Immunology and Allergy, Division of Cardiovascular Medicine, Division of Vascular and Endovascular Surgery, and Department of Pathology at Brigham and Women’s Hospital.

Read more.

Novel Studies Aim to Prevent Rheumatoid Arthritis in High-risk Populations

Researchers in the Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital (BWH) are leading studies designed to prevent the development of rheumatoid arthritis (RA) in patients at high risk for the disease and are participating in the first primary prevention trial for RA in the United States.

Read more.

Advances Newsletters PDFs